Consistent with this, a study by Wang et al. [38] also showed that simvastatin monotherapy increased p21 and p27 by decreasing skp2 leading to the activation of AMPK in hepatocellular carcinoma. Here, CDKN1B is linked to hepatocellular carcinoma.